Cybin (HELP) Accumulated Expenses (2021 - 2026)
Cybin (HELP) posted quarterly Accumulated Expenses of $19.4 million for Q1 2026, up 29.82% year-on-year from $14.9 million in Q1 2025, and up 19.77% on a QoQ basis from $16.2 million in Q4 2025.
Cybin (HELP) Accumulated Expenses (2021 - 2026) Analysis & Trends
Cybin (HELP) has reported Accumulated Expenses for 6 consecutive years, with $19.4 million the latest figure, recorded in Q1 2026.
- Quarterly Accumulated Expenses rose 29.82% year-over-year to $19.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.4 million (up 29.82% YoY) and the FY2026 annual result came in at $19.4 million, up 30.05% from the prior year.
- Accumulated Expenses grew to $19.4 million in Q1 2026 per HELP's latest filing, from $16.2 million in the prior quarter.
- Over the last five years, Accumulated Expenses for HELP reached as high as $19.4 million in Q1 2026 and fell as low as $3.2 million in Q4 2022.
- A 5-year average of $8.5 million and a median of $6.7 million in 2023 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Accumulated Expenses plunged 47.95% — and 2025, when it soared 151.77%.
- Year by year, Accumulated Expenses stood at $3.2 million in 2022, then jumped by 85.7% to $6.0 million in 2023, then surged by 59.36% to $9.5 million in 2024, then soared by 69.85% to $16.2 million in 2025, then rose by 19.77% to $19.4 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $19.4 million, $16.2 million, and $13.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.38 Mn |
| Dec 31, 2025 | 16.18 Mn |
| Sep 30, 2025 | 13.36 Mn |
| Mar 31, 2025 | 14.93 Mn |
| Dec 31, 2024 | 9.53 Mn |
| Sep 30, 2024 | 5.31 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 7.28 Mn |
| Dec 31, 2023 | 5.98 Mn |
| Sep 30, 2023 | 6.89 Mn |
| Jun 30, 2023 | 6.47 Mn |
| Feb 28, 2023 | 3.34 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Dec 31, 2021 | 2.42 Mn |
| Sep 30, 2021 | 2.09 Mn |
| Jun 30, 2021 | 2.48 Mn |
| Mar 31, 2021 | 2.21 Mn |